Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
01/11/2006 | CN1235616C Composition for preventing and treating pig's epidemic diarrhea |
01/11/2006 | CN1235614C Chinese traditional medicine composition for treating digestive system cancer and its preparing method |
01/11/2006 | CN1235607C Ointment for treating wound sore and its preparation method |
01/11/2006 | CN1235606C Vaginitis-treating compound Chinese and Western medicine preparation |
01/11/2006 | CN1235599C Arsenic compound recipe for treating tuberculosis and dermatopathy |
01/11/2006 | CN1235598C Process for preparing buccal lozenge contg. compound sede-iodine |
01/11/2006 | CN1235591C Composition for preventing and treating yellow dysentery of piglet |
01/11/2006 | CN1235569C Porous composite material granular blood vessel embolism agent |
01/10/2006 | US6984400 Method of treating restenosis using bisphosphonate nanoparticles |
01/10/2006 | US6984376 Methods of inhibiting dental erosion/discoloration using a beverage composition comprising a long chain polyphosphate |
01/10/2006 | US6983749 Inducing hypothermia and rewarming using a helium-oxygen mixture |
01/05/2006 | WO2006002287A1 Use of targeted oxidative therapeutic formulation in endodontic treatment |
01/05/2006 | WO2006002106A2 Compositions and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
01/05/2006 | WO2006001962A1 Bicarbonate-based peritoneal dialysis solutions |
01/05/2006 | WO2006001784A1 Cosmetic compositions containing fullerene clusters |
01/05/2006 | WO2006001607A1 Oxygen generating composition |
01/05/2006 | WO2006000455A1 Bioactive composition, seawater-based preparation method, use thereof for genital hygiene and device for using same |
01/05/2006 | WO2006000224A2 Compositions comprising strontium and vitamin d and uses thereof |
01/05/2006 | WO2005101019A8 Detection of nitrosylated proteins |
01/05/2006 | WO2005089448A3 Administration of cisplatin by inhalation |
01/05/2006 | WO2005070043A3 Methods for treating non-melanoma cancers with paba |
01/05/2006 | WO2005062810A3 Treatment of primary and metastatic neoplastic diseases with tetraarsenic decaoxide |
01/05/2006 | WO2005011570A3 Calcium carbonate granulation |
01/05/2006 | WO2004105691A3 Pharmaceutical compositions for oral administration comprising lithium carbonate |
01/05/2006 | US20060004072 Microbiological control in animal processing |
01/05/2006 | US20060003981 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
01/05/2006 | US20060003028 Stable oxidizing bromine composition, method of manufacture and use thereof for biofouling control |
01/05/2006 | US20060003027 Composition and method for reducing side effects of indole-3-carbinol and derivatives |
01/05/2006 | US20060003026 Chinese preparation for treating enteritis ulcer colitis and preparation method thereof |
01/05/2006 | US20060003025 comprising from 1300 to 1500 mg/l of Na+, from 4500 to 6500 mg/l of K+, from 50 to 1300 mg/l of Mg++, from 20 to 350 mg/l of ca++, from 4000 to 6000 mg/l of Cl-, a pH of from 4-9, and an osmolality of from 150-700 mOsm/kg; for treating and cleaning the eye |
01/05/2006 | US20060003024 Iodizing agent and process for preparation thereof |
01/05/2006 | US20060003023 Microbicidal composition |
01/05/2006 | US20060003022 Methods and compositions for controlling microorganism populations in the digestive system of animals |
01/05/2006 | US20060003021 Method of treating breast cancer using a combination of vitamin d analogues and other agents |
01/05/2006 | US20060003020 Anti-metastatic ability of mibefradil and gadolinium |
01/05/2006 | US20060003019 Biologically inhibiting material a method of producing said material as well as the use of said material for inhibiting live cells |
01/05/2006 | US20060003018 administering lanthanum oxycarbonates for removing phosphates from blood and/or gastrointestinal tract; dephosphorization |
01/05/2006 | US20060003017 Antioxidants in clusters of structured water |
01/05/2006 | US20060003016 Therapeutic method for endolymphatic hydrops associated diseases |
01/05/2006 | US20060003015 Food composition effective for treatment of oral and throat diseases and method of producing the same |
01/05/2006 | US20060002837 Processes for making rare earth metal oxycarbonates |
01/05/2006 | CA2571611A1 Cell-based therapies for ischemia |
01/05/2006 | CA2571569A1 Use of targeted oxidative therapeutic formulation in endodontic treatment |
01/05/2006 | CA2571449A1 Compositions comprising strontium and vitamin d and uses thereof |
01/05/2006 | CA2571364A1 Method for producing an iron sulfate-based phosphate adsorbent |
01/05/2006 | CA2554799A1 Cosmetic compositions containing fullerene clusters |
01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
01/04/2006 | EP1610800A2 Methods and compositions for increasing the anaerobic working capacity in tissues |
01/04/2006 | EP1237553B1 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
01/04/2006 | EP1214081B1 Superoxidized water based on hypochlorous acid for the treatment of wounds |
01/04/2006 | EP1202744B1 PRODUCTION OF rhPBGD |
01/04/2006 | EP1064004B1 Metal/thiol biocides |
01/04/2006 | CN1714868A Composition and method for reducing side effects of indole-3-carbinol and derivatives |
01/04/2006 | CN1714866A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
01/04/2006 | CN1234426C Topical pharmaceutical formulation |
01/04/2006 | CN1234402C Method for treating bone fracture |
01/04/2006 | CN1234397C Medicine for treating acute and chronic bronchitis, asthma and pulmonary emphysema |
01/04/2006 | CN1234392C External drug of the Chinese traditional medicine for treating acne |
01/04/2006 | CN1234390C Medicine for treating hydrops and hydroncus and preparing method thereof |
01/04/2006 | CN1234380C Fracture setting medicine powder and its preparing process |
01/04/2006 | CN1234378C Chinese medicine for treating bone fracture and its preparing method |
01/04/2006 | CN1234374C Ointment for treating pointed condyloma |
01/04/2006 | CN1234371C Application of nano copper powder for preparing medicine for prophylaxis of osteoporosis and bone fracture |
01/03/2006 | US6982096 Determining a therapeutic dosage of arsenic trioxide based upon the predetermined weight of the patient and administering; Leukemia; lymphomas; solid tumors; anticarcinoma and -tumor agents |
01/03/2006 | US6982084 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
12/29/2005 | WO2005123193A2 Treatments comprising strontium for rheumatic and arthritic diseases and pain |
12/29/2005 | WO2005123192A2 Improving pain treatment with strontium combinations |
12/29/2005 | WO2005123098A2 Preventing gastrointestinal side-effects with strontium salts |
12/29/2005 | WO2005123047A2 Methods of managing multi-tissue injuries |
12/29/2005 | WO2005091872A3 Pharmaceutical composition and method for the transdermal delivery of magnesium |
12/29/2005 | WO2005032480A3 Methods, compositions,, apparatuses containing tetrameric oxygen |
12/29/2005 | WO2004085998A3 Biomimetic hierarchies using functionalized nanoparticles as building blocks |
12/29/2005 | US20050288235 Sodium chloride; dextran, carboxymethyl starch, sodium alginate, pentahydroxyethyl starch, gelatin derivatives or pectin; NaHCO3, KCl, MgSO4, CaCl, calcium gluconate, calcium lactate, sodium lactate, and/or Tris buffer; total Na ion does not exceed equivalent concentration of 6.9% (w/v); traumatic shock |
12/29/2005 | US20050287494 Gingival retraction material |
12/29/2005 | US20050287233 Compositions for preventing or ameliorating multiple risk factor syndromes |
12/29/2005 | US20050287229 Administering to an animal subject in need thereof an effective amount of a composition comprising a clathrate of aliphatic material and monoclinic sulfur, wherein the aliphatic material is encapsulated by the monoclinic sulfur |
12/29/2005 | US20050287228 Method and composition for improving fertility health in female and male animals and humans |
12/29/2005 | US20050287227 Supplement containing carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and method of the same |
12/29/2005 | US20050287226 High potency clinical anti-craving treatment and method of use |
12/29/2005 | US20050287225 Metal cluster nano-compounds for treating tumor diseases |
12/29/2005 | US20050287224 Oxygen generating composition |
12/29/2005 | US20050287112 Antibacterial paint containing nano silver particles and coating method using the same |
12/29/2005 | US20050287071 Formulation for a cement preparation as bone substitute |
12/29/2005 | US20050285073 Permanently linked, rigid, magnetic chains |
12/29/2005 | US20050284822 Environmentally compatible processes compositions and materials treated thereby |
12/29/2005 | DE10297803T5 Granuliertes Kupferoxid für anwuchsverhindernde Beschichtungen Granulated copper antifouling coatings for |
12/29/2005 | DE102005026380A1 Mittel zur Unterdrückung von Entzündungen, umfassend Zinkpyrrolidoncarboxylat Means for suppressing inflammation, comprising zinc pyrrolidonecarboxylate |
12/29/2005 | CA2570503A1 A method of improving the medical treatment of pain |
12/29/2005 | CA2570389A1 Treatments comprising strontium for rheumatic and arthritic diseases and pain |
12/28/2005 | EP1609826A2 Antibacterial paint containing nano silver particles and coating method using the same |
12/28/2005 | EP1609475A1 Remedy or preventive for low turnover bone diseases |
12/28/2005 | EP1609474A1 Method for preparing therapeutic agent for cancer |
12/28/2005 | EP1608405A2 Nitric oxide in treatment of inflammation |
12/28/2005 | EP1608385A2 Therapeutic compositions |
12/28/2005 | EP1608381A2 Novel therapeutic application for a composition |
12/28/2005 | EP1608338A1 Pharmaceutical compositions containing active agents having a lactone group and transition metal ions |
12/28/2005 | EP1608310A2 Methods and compositions for blocking the calcium cascade |
12/28/2005 | EP1286675B8 Use of aqueous selenite solutions for the manufacture of a medicament for the treatment of viral diseases and pigmented spots |